Maintenance of IL-12-responsive CD4+ T cells during a Th2 response in Leishmania major-infected mice

European Journal of Immunology

Volumn 30, Issue 7, 2000, Pages 2007-2014

  Hondowicz, Brian D ^a   Park, Audrey Y ^a   Elloso, M Merle ^a   Scott, Phillip ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cytokine; IL 12; IL 12 receptor; Leishmania; Th1 Th2 cell

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; GENETIC STABILITY; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH2 CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, PROTOZOAN; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; IMMUNOPHENOTYPING; INTERLEUKIN-12; L-SELECTIN; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; TH1 CELLS; TH2 CELLS;

EID: 0033924551     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200007)30:7<2007::AID-IMMU2007>3.0.CO;2-W     Document Type: Article

References (23)

1. Nabors, G. S., Afonso, L. C. C., Farrell, J. P. and Scott, P., Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin-12 and pentostam. Proc. Natl. Acad. Sci. USA 1995. 92: 3142-3136.
2. Nabors, G. S., Nolan, T., Croop, W., Li, J. and Farrell, J. P., The influence of the site of parasite inoculation on the development of TM and Th2 type immune responses in (BALB/c c C57BL/6) F1 mice infected with Leishmania major. Parasite Immunol. 1995. 17: 569-579.
3. Hondowicz, B. D., Scharton-Kersten, T. M., Jones, D. E. and Scott, P., Leishmania mayor-infected C3H mice treated with anti-IL-12 develop but do not maintain a Th2 response. J. Immunol. 1997. 159: 5024-5031.
4. Wu, C. Y., Warrier, R., Carvajal, D. M., Chua, A. O., Minetti, L. J., Chizzonite, R., Mongini, P. K., Stern, A. S., Gubler, U., Presky, D. H. and Gately, M. K., Biological function and distribution of human interleukin-12 receptor beta chain. Eur. J. Immunol. 1996. 26: 345-350.
5. Desai, B. B., Quinn, P. M., Wolitzky, A. G., Mongini, P. K., Chizzonite, R. and Gately, M. K., IL-12 receptor. II. Distribution and regulation of receptor expression. J. Immunol. 1992. 148: 3125-3132.
6. Gately, M. K., Renzetti, L. M., Magram, J., Stern, A. S., Adorini, L., Gubler, U. and Presky, D. H., The interleukin-12/ interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 1998. 16: 495-521.
7. Guler, M. L., Gorham, J. D., Hsieh, C.-S., Mackey, A. J., Steen, R. G., Dietrich, W. F. and Murphy, K. M., Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development. Science 1996. 271: 984-986.
8. Szabo, S. J., Dighe, A. S., Gubler, U. and Murphy, K. M., Regulation of the interleukin-12 β2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 1997. 185: 817-824.
9. Szabo, S. L., Jacobson, N. G., Dighe, A. S., Gubler, U. and Murphy, K. H., Developmental commitment to the Th2 lineage by extenction of IL-12 signaling. Immunity 1995. 2: 665-675.
10. Jones, D., Elloso, M. M., Showe, L., Williams, D., Trinchieri, G. and Scott, P., Differential regulation of the interleukin-12 receptor during the innate immune response to Leishmania major. Infect. Immun. 1998. 66: 3818-3824.
11. Himmelrich, H., Parra-Lopez, C., Tacchini-Cottier, F., Louis, J. A. and Lanoois, P., The IL-4 rapidly produced in BALB/mice after infection with Leishmania major down-regulates IL-12 receptor beta 2-chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12. J. Immunol. 1998. 161: 6156-6163.
12. Jacobson, N. G., Szabo, S. J., Guler, M. L., Gorham, J. D. and Murphy, K. M., Regulation of interleukin-12 signal transduction during T helper cell phenotype development. Res. Immunol. 1996. 146: 446-456.
13. Scharton-Kersten, T., Afonso, L. C. C., Wysocka, M., Trinchieri, G. and Scott, P., IL-12 is required for Natural Killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 1995. 154: 5320-5330.
14. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 1994. 179: 589-600.
15. Mocci, S. and Coffman, R. L., The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania mayor-specific T cell populations. J. immunol. 1997. 158: 1559-1564.
16. +, major histocompatibility complex class II-restricted T cells derived from lymphoid tissues of naive mice. J. Exp. Med. 1993. 178: 101-111.
17. Sypek, J. P., Chung, C. L., Mayor, S. E. H., Subramanyam, J. M., Goldman, S. J., Sieburth, D. S., Wolf, S. F. and Schaub, R. G., Resolution of cutaneous leishmaniasis: interleukin initiates a protective Th1 immune response. J. Exp. Med. 1993. 177: 1797-1802.
18. Hondowicz, B. and Scott, P., The role of IL-12 in modulating an established Th2 response in experimental leishmaniasis. Res. Immunol. 1995. 146: 560-565.
19. Guler, M. L., Gorham, J. D., Dietrich, W. F., Murphy, T. L., Steen, R. G., Parvin, C. A., Fenoglio, D., Grupe, A., Peltz, G. and Murphy, K. M., Tpm1, a locus controlling IL-12 responsiveness, acts by a cell-autonomous mechanism. J. Immunol. 1999. 162: 1339-1347.
20. Jung, T. M., Gallatin, W. M., Weissman, I. L. and Dailay, M. O., Down-regulation of homing receptors after T cell activation. J. Immunol. 1988. 141: 4110-4117.
21. Jung, T. M. and Dailey, M. O., Reversibility of loss of homing receptor expression following activation. Adv. Exp. Med. Biol. 1988. 237: 519-524.
22. Sacks, D. H. and Perkins, P. V., Identification of an infective stage of Leishmania promastigotes. Science 1984. 223: 1417-1410.
23. Scott, P., Pearce, E., Natovitz, P. and Sher, A., Vaccination against cutaneous leishmaniasis in a murine model. II. Immunologie properties of protective and nonprotective subfractions of soluble promastigote extract. J. Immunol. 1987. 139: 3118-3125.